Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Psychiatry

• Publication date

  1991-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/AJP.148.4.517PMID 2006699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity.

  1990cited by this paper
• Continuing in treatment as a form of selection bias.

  1989cited by this paper
• Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.

  1989cited by this paper
• Continuing in treatment as a form of selection bias.

  1989cited by this paper
• Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.

  1989cited by this paper
• Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants.

  1989cited by this paper
• One-year follow-up of panic disorder. Outcome and prognostic factors.

  1988cited by this paper
• Benzodiazepine withdrawal: a review of the evidence.

  1988cited by this paper
• Benzodiazepine withdrawal: overview and implications for the treatment of anxiety.

  1988cited by this paper
• Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

  1988cited by this paper
• Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

  1988cited by this paper
• Natural Course and Spontaneous Remissions of Untreated Anxiety Disorders: Results of the Munich Follow-up Study (MFS)

  1988cited by this paper
• Agoraphobia with panic attacks: 1-year prospective follow-up.

  1987cited by this paper
• Anxiety disorders: A long‐term prospective and retrospective follow‐up study of former inpatients suffering from an anxiety neurosis or phobia

  1987cited by this paper
• Discontinuation of alprazolam treatment in panic patients.

  1987cited by this paper
• Two-year follow-up of exposure and imipramine treatment of agoraphobia.

  1986cited by this paper
• Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.

  1986cited by this paper
• Seizures following the withdrawal of alprazolam.

  1986cited by this paper
• One-year follow-up of anxious patients treated with diazepam.

  1986cited by this paper
• Withdrawal syndrome with gradual tapering of alprazolam.

  1986cited by this paper
• A withdrawal syndrome after abrupt discontinuation of alprazolam.

  1985cited by this paper
• The Anxiety Disease

  1984cited by this paper
• Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.

  1984cited by this paper
• Panic disorder and primary unipolar depression. A comparison of background and outcome.

  1983cited by this paper
• Gradual withdrawal of diazepam after long-term therapy.

  1983cited by this paper
• Treatment of Phobias: I. Comparison of Imipramine Hydrochloride and Placebo

  1983cited by this paper
• Alprazolam: Pharmacokinetics, Clinical Efficacy, and Mechanism of Action

  1982cited by this paper
• Relapse after short-term drug therapy in neurotic outpatients.

  1980cited by this paper
• Prazepam and lorazepam, two new benzodiazepines.

  1978cited by this paper
• The management of severe agoraphobia: A comparison of iproniazid and systematic desensitization

  1973cited by this paper
• Social Class and Mental Illness

  1964cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis

  2024cites this paper
• Absence of definitive scientific evidence that benzodiazepines could hinder the efficacy of exposure‐based interventions in adults with anxiety or posttraumatic stress disorders: A systematic review of randomized clinical trials

  2020cites this paper
• Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development

  2019cites this paper
• Center Predictors of Long-Term Benzodiazepine Use in Chronic Obstructive Pulmonary Disease and Posttraumatic Stress Disorder.

  2019cites this paper
• Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.

  2018cites this paper
• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder

  2018cites this paper
• Long-Term Benzodiazepine Use in Posttraumatic Stress Disorder and Chronic Obstructive Pulmonary Disease

  2018cites this paper
• Antidepressants and benzodiazepines for panic disorder in adults.

  2016cites this paper
• Emotions and Cognitions: A Critique of the Dichotomous View of Mental Function

  2014cites this paper
• A Comparison between Psychosocial and Pharmacological Treatments

  2014cites this paper
• Benzodiazepines versus placebo for panic disorder in adults.

  2013cites this paper
• Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks

  2012cites this paper
• Evidence-based pharmacotherapy of panic disorder: an update.

  2012cites this paper
• Generalised Anxiety Disorder

  2012cites this paper
• Management of Panic Anxiety with Agoraphobia by Using Cognitive Behavior Therapy

  2012cites this paper
• The role of alprazolam for the treatment of panic disorder in Australia

  2012cites this paper
• The Efficacy and Safety of Alprazolam Versus Other Benzodiazepines in the Treatment of Panic Disorder

  2011cites this paper
• Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.

  2010cites this paper
• Combined Cognitive Behavioral and Pharmacologic Treatment Strategies: Current Status and Future Directions

  2010cites this paper
• Assessment and treatment of psychological causes of chest pain.

  2010cites this paper
• Race differences in mental health services for depression and anxiety: Treatment rates, settings, and quality among whites, blacks, and Latinos in the Collaborative Psychiatric Epidemiology Surveys

  2010cites this paper
• Chapter 21 – Comparison between Psychosocial and Pharmacological Treatments

  2010cites this paper
• Sedative-Hypnotics and Anxiolytics

  2010cites this paper
• Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications.

  2010cites this paper
• Cognitive and Behavioral Therapies

  2008cites this paper
• Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

  2008cites this paper
• A Self-Help Handout for Benzodiazepine Discontinuation Using Cognitive Behavioral Therapy

  2008cites this paper
• Attending to Emotional Cues for Drug Abuse: Bridging the Gap Between Clinic and Home Behaviors

  2007cites this paper
• 1995 The Institute of Mind and Behaviour

  2007cites this paper
• Three-year medication prophylaxis in panic disorder: to continue or discontinue? A naturalistic study.

  2007cites this paper
• Consumo terapéutico y extraterapéutico de Benzodiacepinas en pacientes con dependencia a opiáceos incluidos en el ensayo PEPSA: Notas metodológicas sobre el proyecto de investigación

  2007cites this paper
• Psychiatric Drugging: Forty Years of Pseudo-Science, Self-Interest, and Indifference to Harm

  2007cites this paper
• Combining Cognitive-Behavioral Therapy and Pharmacotherapy for the Treatment of Panic Disorder

  2006cites this paper
• APPORT DE LA THÉRAPIE COGNITIVO-COMPORTEMENTALE DANS LE SEVRAGE DES BENZODIAZÉPINES : ANALYSE DES ÉTUDES D'EFFICACITÉ

  2006cites this paper
• Anxiety in primary care

  2006cites this paper
• Regular prescriptions for benzodiazepines: a cross-sectional study of outpatients at a university hospital.

  2006cites this paper
• Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.

  2006cites this paper
• AVANCES EN PSICOFARMACOLOGÍA Uso de mirtazapina en el trastorno de pánico

  2006cites this paper
• Combined Psychotherapy and Pharmacotherapy for Mood and Anxiety Disorders in Adults: Review and Analysis

  2006cites this paper
• Emotional exposure in the treatment of substance use disorders: conceptual model, evidence, and future directions.

  2005cites this paper
• Behavioral Treatments of Panic Disorder with Agoraphobia : Treatment Process and Determinants of Change

  2005cites this paper
• Evidence-based pharmacotherapy of panic disorder.

  2005cites this paper
• Clinical Pharmacology, Clinical Efficacy, and Behavioral Toxicity of Alprazolam: A Review of the Literature

  2004cites this paper
• Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.

  2004cites this paper
• Changes in Symptoms and Adverse Events After Discontinuation of Atomoxetine in Children and Adults With Attention Deficit/Hyperactivity Disorder: A Prospective, Placebo-Controlled Assessment

  2004cites this paper
• Cognitive-behavioral therapy for the treatment of anxiety disorders.

  2004cites this paper
• Review of the long‐term effectiveness of cognitive behavioral therapy compared to medications in panic disorder

  2003cites this paper
• Diagnosis and Treatment of Panic Disorder

  2003cites this paper
• Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia.

  2003cites this paper
• Effectiveness: the treatment of panic disorder in the real world

  2003cites this paper
• A contemporary protocol to assist primary care physicians in the treatment of panic and generalized anxiety disorders.

  2003cites this paper
• Cognitive-Behavioral Therapy for Panic Disorder: A Review of Treatment Elements, Strategies, and Outcomes

  2003cites this paper
• Increased Probability of Remaining in Remission from Panic Disorder with Agoraphobia after Drug Treatment in Patients Who Received Concurrent Cognitive-Behavioural Therapy: A Follow-Up Study

  2002cites this paper
• Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy.

  2002cites this paper
• INTERNATIONAL ADDICTIONS INFOLINE

  2002cites this paper
• As-needed use of benzodiazepines in managing clinical anxiety: incidence and implications.

  2002cites this paper
• Alprazolam-induced panic disorder.

  2002cites this paper
• ALPRAZOLAM: profilo farmacoeconomico nei disturbi d’ansia e da attacchi di panico

  2002cites this paper
• Cognitive therapy for panic disorder: The impact of medication discontinuation on symptoms

  2001cites this paper
• A pilot open trial of brief psychodynamic psychotherapy for panic disorder.

  2001cites this paper
• Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence.

  2001cites this paper
• Empirically supported treatments for panic disorder: costs, benefits, and stepped care.

  2000cites this paper
• Interruption of selective serotonin reuptake inhibitor treatment

  2000cites this paper
• PRODUCT MONOGRAPH

  2000cites this paper
• New developments in panic disorder

  2000cites this paper
• A Prospective Naturalistic Study of 326 Panic-Agoraphobic Patients Treated with Antidepressants

  2000cites this paper
• [Causes of failure in psychopharmacological treatment of anxiety disorder].

  1999cites this paper
• Similitude in modern pharmacology

  1999cites this paper
• Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies.

  1999cites this paper
• Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association.

  1998cites this paper
• Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?

  1998cites this paper
• Psychopharmacological Treatment of Panic Disorder

  1998cites this paper
• Anxiety disorders, comorbid substance abuse, and benzodiazepine discontinuation: implications for treatment.

  1997cites this paper
• Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group.

  1997cites this paper
• Anxiety disorders, comorbid substance abuse, and benzodiazepine discontinuation: implications for treatment.

  1997cites this paper
• The Place of Selective Serotonin Reuptake Inhibitors in the Treatment of Panic Disorder

  1997cites this paper
• The psychological and pharmacological treatment of panic disorder and agoraphobia in primary care

  1997cites this paper
• Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment

  1996cites this paper
• Diazepam versus alprazolam for the treatment of panic disorder.

  1996cites this paper
• An integrated treatment approach to panic disorder.

  1996cites this paper
• [Benzodiazepine withdrawal with carbamazepine].

  1996cites this paper
• The effectiveness of cognitive-behavior therapy for panic disorder without concurrent medication treatment: a reply to Power and Sharp

  1996cites this paper
• Alprazolam withdrawal symptoms in agoraphobia with panic disorder: observations from a controlled Anglo-Canadian study

  1996cites this paper
• Does Brief Dynamic Psychotherapy Reduce the Relapse Rate of Panic Disorder?

  1996cites this paper
• Does Brief Dynamic Psychotherapy Reduce the Relapse Rate of Panic Disorder

  1996cites this paper
• Current benzodiazepine issues

  1995cites this paper
• Cognitive-behavior therapy and the longitudinal course of panic disorder.

  1995cites this paper
• The longitudinal course and outcome of panic disorder.

  1995cites this paper
• Brief cognitive-behavioral versus nondirective therapy for panic disorder.

  1995cites this paper
• Integrating Behavioral Therapies with Medications in the Treatment of Drug Dependence. Proceedings of a meeting. June 10-11, 1993.

  1995cites this paper
• The effects of central cholecystokinin receptor blockade on hypothalamic-pituitary-adrenal and symptomatic responses to overnight withdrawal from alprazolam.

  1995cites this paper
• Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization.

  1995cites this paper
• Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment.

  1995cites this paper
• Long-Term Effects of Behavioural Treatment for Panic Disorder with Agoraphobia

  1995cites this paper
• The benzodiazepine withdrawal syndrome.

  1994cites this paper
• Treatment of alprazolam withdrawal with chlordiazepoxide substitution and taper.

  1994cites this paper
• Lactate-induced anxiety after imipramine and diazepam treatment.

  1994cites this paper
• Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.

  1994cites this paper
• Do benzodiazepines have a role in chronic pain management?

  1994cites this paper
• Alprazolam and Exposure for Panic Disorder with Agoraphobia

  1994cites this paper